Altai Protocol Library
Our protocol library curated since 2015 with over 1,000 protocols forms the basis of all our Oncology software solutions
New Protocol: Oral Decitabine/Cedazuridine with Venetoclax for AML
This single-centre phase 2 study demonstrates that oral ASTX727 plus venetoclax is effective and tolerable in older or unfit patients with acute myeloid leukemia, inducing rapid re
New Indication: Zongertinib for HER2-Mutated Advanced NSCLC
In this phase 1b multicohort study, first-line zongertinib demonstrated a 76% objective response rate with durable responses and a median progression-free survival of 14.4 months i
New Protocol: Periop Toripalimab with Chemotherapy for Esophageal Cancer
In this phase II randomized trial with 3-year follow-up, perioperative toripalimab plus chemotherapy significantly improved event-free survival and overall survival compared to che
New Reference: Retifanlimab with Carboplatin – Paclitaxel for Advanced Anal Cancer
In this phase 3 randomized trial of patients with advanced squamous cell carcinoma of the anal canal, retifanlimab combined with carboplatin-paclitaxel significantly improved progr
New Reference: Relacorilant with nab-Paclitaxel for Platinum-Resistant Ovarian Cancer
In this phase 3 trial of patients with platinum-resistant ovarian cancer, relacorilant combined with nab-paclitaxel significantly improved overall survival by extending median surv
New Protocol: Pembrolizumab and Paclitaxel for Recurrent Ovarian Cancer
This phase 3 study showed that adding pembrolizumab to weekly paclitaxel, with or without bevacizumab, significantly improved progression-free survival and overall survival in pati
New Reference: Lenvatinib with Pembrolizumab in Head and Neck Cancer
This phase III study evaluated lenvatinib plus pembrolizumab versus placebo plus pembrolizumab in patients with PD-L1 positive recurrent or metastatic head and neck squamous cell c
New Reference: Lenalidomide-Rituximab for Indolent Non-Hodgkin Lymphoma
In the phase III AUGMENT trial with 5-year follow-up, lenalidomide plus rituximab significantly improved progression-free survival compared with rituximab plus placebo in patients
New Drug: Gedatolisib for ER+ Advanced Breast Cancer
This phase III randomized trial demonstrated that adding gedatolisib to fulvestrant, with or without palbociclib, significantly improved progression-free survival compared to fulve
Our Solutions
Articles
Computerized Chemotherapy Order Entry
Oncology care is inherently complex — with evolving treatment regimens, biomarker-specific indications, organ-based dosing, and rapidly changing guidelines. In this landscape, consistency and clarity become essential not only for safety, but also for quality and equity. This is where a centralized protocol library becomes a game-changer …
Chemotherapy isn’t just about selecting a protocol — it’s about delivering it safely, on time, and without miscommunication. This article walks through the full treatment workflow from oncologist to pharmacist to infusion nurse, and shows how Altai Oncology creates a unified, structured order that eliminates delays, errors, and manual rework.